Mylan's Generic Oracea Infringes Galderma IP: Judge
A Delaware federal judge on Friday found that Mylan Pharmaceuticals Inc.'s efforts to bring a generic version of the rosacea drug Oracea to the market infringed a valid patent held by...To view the full article, register now.
Already a subscriber? Click here to view full article